COVID-19 Impact on Rheumatic Patients

Completed

• Conditions: COVID
• Interventions: Behavioral: self-administered structured questionnaire

• Registration Number: NCT04407299
• Lead Sponsor: Cairo University

Brief Summary

A study to assess the impact of coronavirus disease 2019 (COVID-19) pandemic on the attitude, behaviour and mental health of rheumatic patients and to compare them with healthy individuals.

Detailed Description

To assess the impact of coronavirus disease 2019 (COVID19) pandemic on the attitude, behaviour and mental health of rheumatic patients and to compare them with healthy individual. This is cross-sectional survey, 360 participants were included and divided into cases group composed of 180 patients with rheumatic diseases and control group composed of 180 healthy people. Data were collected via a self-administered structured questionnaire (Google form) which was sent to participants via social networks and emails to different rheumatic patients and healthy individuals. Mental health was measured by the five-item Brief Symptom Rating Scale (BSRS-5).

Conclusion: Mental health should be addressed in the same manner we deal with the infectious disease itself, being of no less importance. It is essential for mental health professionals provide psychological support to vulnerable populations, including the infected and chronically ill patients and their families, individuals, communities and health care workers.

Study Timeline

• Study Start: 2020-04-20
• Primary Completion: 2020-05-10
• Study Completion: 2020-05-20
• Study First Submitted: 2020-05-23
• Study First Submitted QC: 2020-05-27
• Study First Posted: 2020-05-29
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-13
• Last Update Posted: 2020-07-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 360

Inclusion Criteria

• adult patient with diagnosed rheumatic disease

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
1	self-administered structured questionnaire	180 patients diagnosed with autoimmune rheumatic disease. Patients are RA SLE Rhupus AS Behcet Sjogren Vasculitis FM Polymyalgia APA Sarcoidosis IBD Scleroderma DM PSA Mixed
2	self-administered structured questionnaire	control group composed of 180 healthy individuals (matched for age and sex)

Primary Outcome Measures

Name	Time	Method
Score of five-item Brief Symptom Rating Scale (BSRS-5)	3 weeks	7. Six questions for mental health assessment for patients and controls: Mental health was measured by the five-item Brief Symptom Rating Scale (BSRS-5) which was derived from the 50-item BSRS

Trial Locations

Locations (1)

Kasr Alainy Hospital; 🇪🇬 Cairo, Non-US/Non-Canadian, Egypt